Jane Street
BEAM icon

Jane Street’s Beam Therapeutics BEAM Stock Holding History

Jane Street’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.44M Buy
144,300
+77,700
+117% +$2.16M ﹤0.01% 4109
2025
Q4 		$1.85M Sell
66,600
-14,900
-18% -$380K ﹤0.01% 4966
2025
Q3 		$1.98M Sell
81,500
-1,800
-2% -$35.8K ﹤0.01% 4960
2025
Q2 		$1.42M Buy
83,300
+15,200
+22% +$265K ﹤0.01% 4980
2025
Q1 		$1.33M Buy
+68,100
New +$1.78M ﹤0.01% 5051
2024
Q4 		– Sell
-60,800
Closed -$1.49M – 9388
2024
Q3 		$1.49M Sell
60,800
-256,600
-81% -$6.63M ﹤0.01% 5061
2024
Q2 		$7.44M Buy
317,400
+283,700
+842% +$6.97M ﹤0.01% 2397
2024
Q1 		$1.11M Buy
33,700
+3,300
+11% +$103K ﹤0.01% 5216
2023
Q4 		$827K Sell
30,400
-282,200
-90% -$7.01M ﹤0.01% 5900
2023
Q3 		$7.52M Buy
312,600
+273,500
+699% +$7.33M ﹤0.01% 2096
2023
Q2 		$1.25M Buy
39,100
+16,400
+72% +$532K ﹤0.01% 4862
2023
Q1 		$695K Sell
22,700
-5,600
-20% -$221K ﹤0.01% 5729
2022
Q4 		$1.11M Sell
28,300
-213,200
-88% -$9.55M ﹤0.01% 4831
2022
Q3 		$11.5M Buy
241,500
+208,500
+632% +$11.9M 0.01% 1557
2022
Q2 		$1.28M Sell
33,000
-11,300
-26% -$449K ﹤0.01% 5028
2022
Q1 		$2.54M Buy
44,300
+36,300
+454% +$2.38M ﹤0.01% 4288
2021
Q4 		$638K Sell
8,000
-10,500
-57% -$899K ﹤0.01% 6802
2021
Q3 		$1.61M Sell
18,500
-49,600
-73% -$4.98M ﹤0.01% 4930
2021
Q2 		$8.77M Buy
68,100
+20,400
+43% +$1.63M ﹤0.01% 1869
2021
Q1 		$3.82M Buy
47,700
+33,400
+234% +$3.18M ﹤0.01% 2825
2020
Q4 		$1.17M Buy
+14,300
New +$703K ﹤0.01% 4400

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Jane Street's BEAM Position: Q3 2025 in Review

Jane Street sold out of Beam Therapeutics (BEAM) in Q3 2025, closing a stake of 310,010 shares — an estimated $6.17M sold.

Jane Street first reported a position in BEAM in Q4 2020 and held it in 18 quarters. The position peaked at $10.5M in Q2 2024. 218 funds tracked by Wall St. Rank hold BEAM as of Q3 2025.

  • Jane Street reported no remaining Beam Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Jane Street sold 310,010 Beam Therapeutics shares in Q3 2025, an estimated $6.17M.
  • Jane Street first reported a position in Beam Therapeutics in Q4 2020 and held it in 18 quarters.
  • Jane Street's Beam Therapeutics position peaked at $10.5M in Q2 2024.
  • 218 funds tracked by Wall St. Rank held Beam Therapeutics as of Q3 2025.

Based on Jane Street's 13F filing for Q3 2025, filed 14 Nov 2025.